Comparing Airsupra vs Symbicort
| Airsupra (albuterol / budesonide) | Symbicort (budesonide / formoterol) |
|
|---|
| Airsupra (albuterol / budesonide) | Symbicort (budesonide / formoterol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Asthma. Airsupra may also be used for purposes not listed in this medication guide. |
Prescription only
Symbicort is a combination inhaler that contains budesonide (a corticosteroid) and formoterol (a long-acting bronchodilator). Symbicort should only be used in people with moderate-to-severe asthma... View more |
||||||||||||||||
| More about Airsupra (albuterol / budesonide) | More about Symbicort (budesonide / formoterol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Airsupra has an average rating of 9.9 out of 10 from a total of 7 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Symbicort has an average rating of 6.6 out of 10 from a total of 226 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Airsupra side effects |
View all Symbicort side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Airsupra prices |
View all Symbicort prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Other budesonide / formoterol brands include: Breyna | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
7.1 hours |
7.9 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 869 drugs are known to interact with Airsupra:
|
A total of 846 drugs are known to interact with Symbicort:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
January 10, 2023 |
July 21, 2006 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Dulera
Dulera Inhalers (formoterol and mometasone) are used to treat asthma. Includes Dulera side effects ...
Fasenra
Fasenra injection is used to treat severe eosinophilic asthma in adults and children aged 6 and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.